US Market Opens Up For Henlius After First Shipment

Chinese Biosimilars Developer Marks Milestone Via Intas/Accord Partnership

 
• By Dave Wallace
  
Doors are opening in the US for Henlius (Shutterstock)

More from Biosimilars

More from Generics Bulletin